SCHEMBL7657731

SCHEMBL7657731

CN(C)C1CCc2[nH]c3ccc(NC(=O)c4ccco4)cc3c2C1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.68
MAPT P10636 5/20 0.68
ALDH1A1 P00352 4/20 0.68
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
HPGD P15428 2/20 0.68
KDM4E B2RXH2 1/20 0.68
ALOX15 P16050 1/20 0.68
CASP1 P29466 1/20 0.68
HTR1F P30939 1/20 0.67
RAB9A P51151 10/20 0.49
NPC1 O15118 6/20 0.49
ITK Q08881 1/20 0.45
TP53 P04637 5/20 0.45
PKM P14618 2/20 0.45
TSHR P16473 1/20 0.45
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659552 0.85 HTR1F (0.67) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7656398 0.84 HTR1F (0.81) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7661641 0.84 HTR1F (0.66) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL11334169 0.84 HTR1F (0.74) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7657735 0.83 MEN1 (0.66) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7662531 0.83 HTR1F (0.73) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7664670 0.83 HTR1F (0.65) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7659551 0.83 HTR1F (0.73) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7659484 0.82 HTR1F (0.69) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL7663867 0.82 HTR1F (0.71) SMN1; SMN2MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed